Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Annals of Oncology is Scopus-indexed (Q1, CiteScore 69.6), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Ltd.
Checked against the index lists dated .
ISSN 0923-7534Verify ISSN ↗1569-8041Verify ISSN ↗
Publisher: Elsevier Ltd
Cost to publish: About US$5,080 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 6 / 428 | 98th | Q1 |
| Hematology | 3 / 151 | 98th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1990–present, best quartile Q1, CiteScore 69.6.
Annals of Oncology is Q1 in Oncology (rank 6 of 428) and Q1 in Hematology (rank 3 of 151), by CiteScore 2025.
Annals of Oncology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 69.6, which places it in quartile Q1 at the 98th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 21.715, quartile Q1, with an H-index of 331.
The publisher lists an article processing charge of about US$5,080 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Annals of Oncology is published by Elsevier Ltd. Its print ISSN is 0923-7534 and its online ISSN is 1569-8041.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Annals of Oncology has an h-index of 390 and a 2-year mean of 1.63 citations per paper (OpenAlex). Its Scopus CiteScore is 69.6, quartile Q1. On 2-year citations it ranks #232 of 424 Scopus journals in Oncology.
Annals of Oncology published 5,417 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 89 research articles (2026), authors are most often from Italy (11.1%), China (10.8%) and United States (9.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 390 retracted papers are recorded (5.8 per 1,000 papers). The Problematic Paper Screener flags 3 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.